Artículos

Evaluation of Weight Loss and Adipocytokine Levels after Two Hypocaloric Diets with Different Macronutrient Distribution in Obese Subjects with the rs6923761 Gene Variant of Glucagon-Like Peptide 1 Receptor.

Autores: de Luis DA, Aller R, Izaola O, de la Fuente B, Primo D, Conde R, Sagrado MG.
Continuar leyendo

Expression of genes related to energy metabolism (osteocalcin, FOXO1, insulin receptor, and SOST) in bone cells of Goto-Kakizaki rats and response to bariatric surgery.

Autores: Pérez-Castrillón JL, Riancho JA, de Luis D, Gonzalez-Sagrado M, Domingo-Andres M, Dueñas-Laita A.
Continuar leyendo

Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus.

Autores: de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R, de la Fuente B.
Continuar leyendo

[Anthropometric measures of central abdominal fat and discriminant capacity for metabolic syndrome in a Spanish population].

Autores: Bellido D, López de la Torre M,Carreira J, de Luis D, Bellido V, Soto A, Luengo LM, Hernández A, Vidal J, Becerra A, Ballesteros M.
Continuar leyendo

CLINICAL EFFECTS OF A W3 ENHANCED POWDERED NUTRITIONAL FORMULA IN POSTSURGICAL AMBULATORY HEAD AND NECK CANCER PATIENTS.

Autores: de Luis DA, Izaola O, Cuellar L, Terroba MC, Ventosa M, Martin T, Aller R.
Continuar leyendo

Relation of -55CT polymorphism of UCP3 gene with weight loss and metabolic changes after a high monounsaturated fat diet in obese non diabetic patients.

Autores: De Luis DA, Aller R, Izaola O, De La Fuente B, Conde R, Eiros Bouza JM.
Continuar leyendo

Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets.

Autores: Paoli A, Rubini A, Volek JS, Grimaldi KA.
Continuar leyendo

Insulin analogues: modifications in the structure, molecular and metabolic consequences

Autores: de Luis DA, Romero E.
Continuar leyendo

Potential of incretin-based therapies for non-alcoholic fatty liver disease.

Autores: Samson SL, Bajaj M.
Continuar leyendo

Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists.

Autores: Cuthbertson DJ, Irwin A, Gardner CJ, Daousi C, Purewal T, Furlong N, Goenka N, Thomas EL, Adams VL, Pushpakom SP, Pirmohamed M, Kemp GJ.
Continuar leyendo